Island Pharmaceuticals commences key dengue fever drug trial in Australia
Australian antiviral drug development company, Island Pharmaceuticals Ltd (ASX: ILA), has reached a milestone with the commencement of its Single Ascending Dose (SAD) study for ISLA-101. This well-known drug candidate, repurposed for the prevention and treatment of dengue and other mosquito-borne diseases, represents a major advance in the field. The SAD study, conducted at Scientia […]